| Literature DB >> 29966236 |
Juan Mielgo-Ayuso1,2, Raquel Aparicio-Ugarriza3, Josune Olza4, Javier Aranceta-Bartrina5,6, Ángel Gil7,8, Rosa M Ortega9, Lluis Serra-Majem5,10, Gregorio Varela-Moreiras11,12, Marcela González-Gross13,14.
Abstract
Thiamin, riboflavin, niacin, and vitamin B₆ are essential micronutrients that are mainly involved in energy metabolism; they may prevent the occurrence of developmental abnormalities and chronic degenerative and neoplastic diseases. The aim was to analyze dietary intake and food sources of those four nutrients in subjects (n = 2009) aged 9⁻75 years old from the Spanish ANIBES (Anthropometry, Intake, and Energy Balance in Spain) study. Dietary data were collected by means of a validated, photo-based three-day dietary food record. Underreporting was analysed according to the European Food and Safety Authority (EFSA, Parma, Italy) protocol. Mean (max⁻min) reported intake for the whole population of thiamin was 1.17 ± 0.02 mg/day, (0.30⁻3.44 mg/day), riboflavin 1.44 ± 0.02 mg/day, (0.37⁻3.54 mg/day), niacin 29.1 ± 0.2 mg/day (6.7⁻109 mg/day), and vitamin B₆ 1.54 ± 0.01 mg/day (0.28⁻9.30 mg/day). The main sources of intake for thiamin, niacin, and vitamin B₆ were meat and meat products, and for riboflavin were milk and dairy products. An elevated percentage of the Spanish ANIBES population meets the EFSA recommended intakes for thiamin (71.2%), riboflavin (72.0%), niacin (99.0%), and vitamin B₆ (77.2%).Entities:
Keywords: ANIBES study; b-related vitamins; food intake; misreporting
Mesh:
Substances:
Year: 2018 PMID: 29966236 PMCID: PMC6073544 DOI: 10.3390/nu10070846
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Calculated misreporting cut-off at group and individual levels for the Anthropometry, Intake, and Energy Balance in Spain (ANIBES) study.
| PAL | Misreporting Cut-off | |||
|---|---|---|---|---|
| Group Level | Individual Level | |||
| Lower | Upper | Lower | Upper | |
| Children and adolescents | ||||
| 1.6 | 1.55 | 1.66 | 0.93 | 2.76 |
| 1.8 | 1.73 | 1.86 | 1.04 | 3.10 |
| 2.0 | 1.93 | 2.07 | 1.16 | 3.45 |
| Adults and elderly | ||||
| 1.4 | 1.38 | 1.42 | 0.77 | 2.53 |
| 1.6 | 1.58 | 1.62 | 0.88 | 2.89 |
| 1.8 | 1.77 | 2.83 | 1.00 | 3.25 |
Daily Thiamin, Riboflavin, niacin, and vitamin B6 reported intake by sex and age group in the ANIBES Study population.
| Total | Children 9–12 Years | Adolescents 13–17 Years | Adults 18–64 Years | Elderly 65–75 Years | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SEM | Median (Range) | Mean ± SEM | Median (Range) | Mean ± SEM | Median (Range) | Mean ± SEM | Median (Range) | Mean ± SEM | Median (Range) | ||||||
| Total | 2009 | 1.17 ± 0.02 | 1.07 (0.30–3.44) | 213 | 1.24 ± 0.03 | 1.20 (0.41–3.32) | 211 | 1.28 ± 0.03 | 1.24 (0.41–3.01) | 1655 | 1.18 ± 0.02 | 1.07 (0.30–3.44) | 206 | 1.06 ± 0.03 | 0.97 (0.40–2.69) |
| Men | 1013 | 1.27 ± 0.04 * | 1.15 (0.33–3.44) | 126 | 1.28 ± 0.04 | 1.22 (0.41–3.32) | 137 | 1.35 ± 0.04 | 1.28 (0.41–3.01) | 798 | 1.29 ± 0.05 * | 1.16 (0.33–3.44) | 99 | 1.41 ± 0.04 | 1.00 (0.42–2.69) |
| Women | 996 | 1.07 ± 0.01 | 1.00 (0.30–2.70) | 87 | 1.18 ± 0.04 | 1.15 (0.41–2.70) | 74 | 1.14 ± 0.04 | 1.17 (0.52–2.31) | 857 | 1.07 ± 0.01 | 1.01 (0.30–2.68) | 107 | 0.98 ± 0.03 | 0.89 (0.40–2.17) |
| Total | 2009 | 1.44 ± 0.02 | 1.34 (0.37–3.54) | 213 | 1.56 ± 0.03 | 1.54 (0.50–3.41) | 211 | 1.51 ± 0.04 | 1.43 (0.53–3.82) | 1655 | 1.44 ± 0.02 | 1.33 (0.40–3.54) | 206 | 1.39 ± 0.04 | 1.32 (0.37–4.71) |
| Men | 1013 | 1.53 ± 0.04 * | 1.40 (0.42–3.54) | 126 | 1.62 ± 0.04 | 1.56 (0.50–3.41) | 137 | 1.63 ± 0.05 * | 1.51 (0.55–3.82) | 798 | 1.54 ± 0.05 * | 1.39 (0.42–3.54) | 99 | 1.47 ± 0.07 | 1.32 (0.61–4.71) |
| Women | 996 | 1.35 ± 0.01 | 1.29 (0.37–3.08) | 87 | 1.49 ± 0.05 | 1.49 (0.53–2.57) | 74 | 1.29 ± 0.04 | 1.27 (0.53–2.04) | 857 | 1.36 ± 0.02 | 1.28 (0.40 + 3.47) | 107 | 1.33 ± 0.05 | 1.32 (0.37–2.99) |
| Total | 2009 | 29.1 ± 0.2 | 27.9 (6.7–109.0) | 213 | 28.5 ± 0.5 | 27.5 (8.6–58.4) | 211 | 30.2 ± 0.7 | 30.1 (11.7–73.6) | 1655 | 29.4 ± 0.3 | 28.1 (6.6–109.0) | 206 | 26.0 ± 0.6 | 25.0 (9.1–70.3) |
| Men | 1013 | 31.4 ± 0.3 * | 30.2 (9.8–109.0) | 126 | 29.4 ± 0.7 | 28.9 (8.6–58.4) | 137 | 32.4 ± 0.8 * | 32.0 (11.7–73.6) | 798 | 31.9 ± 0.4 * | 30.6 (12.1–109.0) | 99 | 28.0 ± 1.0 * | 26.2 (9.8–70.3) |
| Women | 996 | 26.7 ± 0.3 | 26.1 (6.7–66.1) | 87 | 27.0 ± 0.8 | 26.1 (13.3–50.6) | 74 | 26.1 ± 0.9 | 26.2 (12.4–45.3) | 857 | 27.1 ± 0.3 | 26.4 (6.7–66.1) | 107 | 24.2 ± 07 | 22.6 (9.1–48.2) |
| Total | 2009 | 1.54 ± 0.01 | 1.44 (0.28–9.30) | 213 | 1.51 ± 0.03 | 1.51 (0.49–4.29) | 211 | 1.54 ± 0.04 | 1.47 (0.62–3.62) | 1655 | 1.55 ± 0.02 | 1.44 (0.28–9.30) | 206 | 1.56 ± 0.05 | 1.39 (0.62–5.29) |
| Men | 1013 | 1.64 ± 0.02 * | 1.51 (0.44–9.30) | 126 | 1.54 ± 0.04 | 1.54 (0.56–4.29) | 137 | 1.62 ± 0.05 * | 1.57 (0.63–3.62) | 798 | 1.65 ± 0.03 * | 1.49 (0.44–9.30) | 99 | 1.71 ± 0.08 * | 1.51 (0.73–5.29) |
| Women | 996 | 1.45 ± 0.02 | 1.37 (0.28–3.94) | 87 | 1.46 ± 0.06 | 1.46 (0.49–3.28) | 74 | 1.40 ± 0.05 | 1.31 (0.62–2.86) | 857 | 1.46 ± 0.02 | 1.39 (0.28–3.94) | 107 | 1.42 ± 0.05 | 1.29 (0.62–3.61) |
Results are expressed as the mean ± standard error of the mean (SEM) and median with range (in brackets); (*) t-tests were used to evaluate differences by sex within the whole population and within each age group. Analysis or analyses of variance (ANOVA) tests were used to calculate differences among age groups (mean values within the same row with unlike superscript letters were significantly different). p < 0.05 was considered statistically significant.
Daily thiamin, riboflavin, niacin, and vitamin B6 reported intake by plausible reporters, non-plausible reporters, and age group in the ANIBES Study population.
| Total | Children 9–12 Years | Adolescents 13–17 Years | Adults 18–64 Years | Elderly 65–75 Years | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SEM | Median (Range) | Mean ± SEM | Median (Range) | Mean ± SEM | Median (Range) | Mean ± SEM | Median (Range) | Mean ± SEM | Median (Range) | ||||||
| Plausible reporters | 543 | 1.42 ± 0.02 | 1.32 (0.60–4.88) | 120 | 1.37 ± 0.04 | 1.31 (0.63–3.32) | 76 | 1.48 ± 0.05 | 1.43 (060–3.01) | 433 | 1.43 ± 0.03 | 1.32 (0.65–4.88) | 45 | 1.31 ± 0.05 | 1.26 (0.74–2.31) |
| Men | 232 | 1.60 ± 0.03 | 1.50 (0.63–4.88) | 68 | 1.42 ± 0.05 | 1.28 (0.63–3.32) | 48 | 1.60 ± 0.06 | 1.53 (0.93–3.01) | 158 | 1.70 ± 0.05 | 1.59 (0.83–4.88) | 24 | 1.42 ± 0.09 | 1.39 (0.90–2.31) |
| Women | 311 | 1.27 ± 0.02 | 1.23 (0.60–2.70) | 52 | 1.30 ± 0.05 | 1.28 (0.79–2.70) | 28 | 1.27 ± 0.07 | 1.27 (0.60–2.31) | 275 | 1.27 ± 0.02 | 1.21 (0.65–2.61) | 21 | 1.18 ± 0.05 | 1.21 (0.74–1.64) |
| Non-Plausible reporters | 1466 | 1.09 ± 0.02 | 0.99 (0.30–3.44) | 93 | 1.08 ± 0.04 | 1.02 (0.41–2.60) | 135 | 1.16 ± 0.03 | 1.11 (0.41–2.48) | 1222 | 1.09 ± 0.03 | 0.99 (0.33–3.44) | 161 | 0.99 ± 0.03 | 0.89 (0.40–2.69) |
| Men | 781 | 1.18 ± 0.04 | 1.07 (0.33–3.44) | 58 | 1.12 ± 0.06 | 1.01 (0.41–2.60) | 89 | 1.22 ± 0.05 | 1.15 (0.41–2.48) | 640 | 1.19 ± 0.05 | 1.08 (0.3–3.4) | 75 | 1.05 ± 0.05 | 0.97 (0.42–2.69) |
| Women | 685 | 0.98 ± 0.01 | 0.92 (0.03–2.68) | 35 | 1.01 ± 0.06 | 1.04 (0.41–1.83) | 46 | 1.06 ± 0.04 | 1.07 (0.52–1.68) | 582 | 0.98 ± 0.01 | 0.92 (0.30–2.68) | 86 | 0.93 ± 0.04 | 0.85 (0.40–2.17) |
| Plausible reporters | 543 | 1.74 ± 0.02 | 1.65 (0.69–6.13) | 120 | 1.72 ± 0.04 | 1.67 (0.96–3.41) | 76 | 1.79 ± 0.06 | 1.77 (0.78–3.46) | 433 | 1.73 ± 0.03 | 1.63 (0.9–6.13) | 45 | 1.77 ± 0.10 | 1.68 (0.85–4.18) |
| Men | 232 | 1.93 ± 0.03 | 1.84 (0.92–6.13) | 68 | 1.77 ± 0.05 | 1.73 (1.04–3.41) | 48 | 1.95 ± 0.08 | 1.92 (1.09–3.46) | 158 | 1.98 ± 0.05 | 1.88 (0.93–6.13) | 24 | 1.96 ± 0.14 | 1.72 (0.92–4.18) |
| Women | 311 | 1.59 ± 0.02 | 1.54 (0.69–3.08) | 52 | 1.65 ± 0.06 | 1.58 (0.96–2.57) | 28 | 1.52 ± 0.06 | 1.51 (0.78–2.04) | 275 | 1.59 ± 0.03 | 1.52 (0.69–3.08) | 21 | 1.56 ± 0.11 | 1.56 (0.85–2.99) |
| Non-Plausible reporters | 1466 | 1.34 ± 0.02 | 1.25 (0.37–3.53) | 93 | 1.36 ± 0.04 | 1.35 (0.50–3.04) | 135 | 1.35 ± 0.04 | 1.34 (0.53–3.82) | 1222 | 1.34 ± 0.03 | 1.24 (0.40–3.54) | 161 | 1.29 ± 0.04 | 1.22 (0.37–4.71) |
| Men | 781 | 1.42 ± 0.04 | 1.30 (0.42–3.53) | 58 | 1.43 ± 0.06 | 1.35 (0.50–3.04) | 89 | 1.45 ± 0.06 | 1.38 (0.55–3.82) | 640 | 1.43 ± 0.06 | 1.30 (0.42–3.54) | 75 | 1.31 ± 0.07 | 1.20 (0.61–4.71) |
| Women | 685 | 1.25 ±0.02 | 1.19 (0.37–2.47) | 35 | 1.25 ± 0.07 | 1.32 (0.53–1.83) | 46 | 1.15 ± 0.05 | 1.09 (0.53–1.84) | 582 | 1.25 ± 0.02 | 1.18 (0.40–3.47) | 86 | 1.27 ± 0.05 | 1.25 (0.37–2.61) |
| Plausible reporters | 543 | 34.1 ± 0.4 | 33.0 (13.3–105.9) | 120 | 31.2 ± 0.6 | 31.1 (18.8–58.4) | 76 | 34.0 ± 1.1 | 33.1 (13.9–68.3) | 433 | 35.1 ± 0.5 | 33.8 (13.3–105.9) | 45 | 32.6 ± 1.5 | 32.9 (16.0–70.3) |
| Men | 232 | 38.1 ± 0.6 | 36.1 (16.0–105.8) | 68 | 32.4 ± 0.8 | 31.6 (18.8–58.4) | 48 | 37.3 ± 1.2 | 35.7 (17.7–68.3) | 158 | 41.1 ± 1.0 | 39.0 (19.8–105.9) | 24 | 35.7 ± 2.3 | 34.1 (16.0–70.3) |
| Women | 311 | 30.9 ± 0.4 | 30.7 (13.3–66.1) | 52 | 29.7 ± 1.0 | 28.4 (19.5–50.6) | 28 | 28.2 ± 1.5 | 28.2 (13.9–45.3) | 275 | 31.6 ± 0.5 | 30.8 (13.3–66.1) | 21 | 29.0 ± 1.5 | 29.8 (16.6–39.9) |
| Non-Plausible reporters | 1466 | 27.0 ± 0.2 | 25.8 (6.7–109.0) | 93 | 25.0 ± 0.8 | 24.3 (8.6–46.1) | 135 | 28.1 ± 0.8 | 27.6 (11.7–73.6) | 1222 | 27.4 ± 0.3 | 26.1 (6.7–109.0) | 161 | 24.2 ± 0.6 | 22.8 (9.1–61.8) |
| Men | 781 | 29.1 ± 0.3 | 27.6 (8.6–1090.) | 58 | 26 ± 1 | 26 (9–46) | 89 | 29.7 ± 1.0 | 28.5 (11.7–73.6) | 640 | 29.6 ± 0.4 | 28.1 (12.1–109.0) | 75 | 25.5 ± 0.9 | 24.9 (9.8–61.8) |
| Women | 685 | 24.7 ± 0.3 | 24.1 (6.7–53.2) | 35 | 46 | 24.9 ± 1.1 | 24.5 (12.4–43.5) | 582 | 25.0 ± 0.3 | 24.6 (6.7–53.2) | 86 | 23.1 ± 0.7 | 21.9 (9.1–48.2) | ||
| Plausible reporters | 543 | 1.83 ± 0.03 | 1.72 (0.57–7.71) | 120 | 1.66 ± 0.04 | 1.63 (0.83–4.29) | 76 | 1.80 ± 0.06 | 1.81 (0.62–3.62) | 433 | 1.85 ± 0.03 | 1.73 (0.57–7.71) | 45 | 2.06 ± 0.12 | 1.89 (0.99–5.29) |
| Men | 232 | 2.05 ± 0.04 | 1.90 (0.85–7.71) | 68 | 1.71 ± 0.06 | 1.68 (0.87–4.29) | 48 | 1.92 ± 0.07 | 1.86 (1.05–3.62) | 158 | 2.20 ± 0.07 | 2.06 (0.85–7.71) | 24 | 2.35 ± 0.19 | 2.11 (1.12–5.29) |
| Women | 311 | 1.7 ± 0.0 | 1.65 (0.57–3.94) | 52 | 1.58 ± 0.06 | 1.53 (0.83–3.16) | 28 | 1.60 ± 0.10 | 1.49 (0.62–2.86) | 275 | 1.66 ± 0.03 | 1.60 (0.57–3.94) | 21 | 1.74 ± 0.10 | 1.71 (0.99–3.01) |
| Non-Plausible reporters | 1466 | 1.43 ± 0.01 | 1.33 (0.28–9.30) | 93 | 1.32 ± 0.05 | 1.30 (0.49–3.28) | 135 | 1.39 ± 0.04 | 1.34 (0.63–3.16) | 1222 | 1.44 ± 0.02 | 1.33 (0.28–9.30) | 161 | 1.42 ± 0.04 | 1.31 (0.62–3.72) |
| Men | 781 | 1.49 ± 0.02 | 1.39 (0.44–9.30) | 58 | 1.34 ± 0.06 | 1.37 (0.56–2.50) | 89 | 1.46 ± 0.06 | 1.39 (0.63–3.16) | 640 | 1.51 ± 0.03 | 1.39 (0.44–9.30) | 75 | 1.50 ± 0.06 | 1.39 (0.73–3.72) |
| Women | 685 | 1.35 ± 0.02 | 1.26 (0.28–3.61) | 35 | 1.28 ± 0.09 | 1.25 (0.49–3.28) | 46 | 1.28 ± 0.05 | 1.2 (0.70–2.21) | 582 | 1.36 ± 0.02 | 1.28 (0.28–3.17) | 86 | 1.34 ± 0.05 | 1.21 (0.62–3.61) |
Results are expressed as the mean standard error of the mean and median with range (in brackets). There were significant differences between plausible and non-plausible reporters for the whole population and within sexes into each age group (p < 0.05), except for vitamin B6 in the children, adults and elderly.
Percentage of the population with adequate intake of thiamin, riboflavin, niacin, and vitamin B6, for the whole population and for the plausible energy reporters by age groups.
| Total | Children 9–12 Years | Adolescents 13–17 Years | Adults 18–64 Years | Elderly 65–75 Years | |
|---|---|---|---|---|---|
| Whole population | 71.2 | 91.5 | 77.7 | 70.8 | 61.2 |
| Men | 75.9 | 92.9 | 81.8 | 74.9 | 70.7 |
| Women | 66.5 | 89.7 | 70.3 | 67.0 | 52.3 |
| Plausible reporters | 93.6 | 99.2 | 90.8 | 91.9 | 93.3 |
| Men | 98.3 | 98.5 | 95.8 | 97.5 | 100.0 |
| Women | 90.0 | 100.0 | 82.1 | 88.7 | 85.7 |
| Whole population | 72.0 | 92.5 | 83.4 | 70.2 | 66.5 |
| Men | 75.4 | 95.2 | 86.9 | 74.3 | 67.7 |
| Women | 68.5 | 88.5 | 77.0 | 66.4 | 65.4 |
| Plausible reporters | 91.3 | 100.0 | 98.7 | 89.6 | 84.4 |
| Men | 97.8 | 100.0 | 100.0 | 97.5 | 95.8 |
| Women | 68.5 | 100.0 | 96.4 | 85.1 | 71.4 |
| Whole population | 99.0 | 100.0 | 99.5 | 98.9 | 97.6 |
| Men | 99.6 | 100.0 | 100.0 | 99.7 | 98.0 |
| Women | 98.3 | 100.0 | 98.6 | 98.1 | 97.2 |
| Plausible reporters | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Men | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Women | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Whole population | 77.2 | 89.7 | 83.4 | 76.0 | 78.6 |
| Men | 79.9 | 92.1 | 87.6 | 78.2 | 86.9 |
| Women | 74.5 | 86.2 | 75.7 | 74.0 | 71.0 |
| Plausible reporters | 93.4 | 97.5 | 93.4 | 91.9 | 97.8 |
| Men | 99.1 | 98.5 | 100.0 | 99.4 | 100.0 |
| Women | 89.1 | 96.2 | 82.1 | 87.6 | 95.2 |
Results are expressed in percentage. Recommended daily intakes for Europe for thiamin [4], riboflavin [8], niacin [12], and vitamin B6 [15]. Adequacy intake was calculated comparing with 80% of the EFSA PRI or AI.
Figure 1Contribution of food sources to the daily thiamin, riboflavin, niacin vitamins B6 intake in the total ANIBES population.